EMBL-EBI | Chemical Biology | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:63916 - iloprost

Default Structure
ChEBI IDCHEBI:63916
ChEBI Nameiloprost
Stars
DefinitionA carbobicyclic compound that is prostaglandin I2 in which the endocyclic oxygen is replaced by a methylene group and in which the (1E,3S)-3-hydroxyoct-1-en-1-yl side chain is replaced by a (3R)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl group. A synthetic analogue of prostacyclin, it is used as the trometamol salt (generally by intravenous infusion) for the treatment of peripheral vascular disease and pulmonary hypertension.
Last Modified22 February 2017
SubmitterGareth Owen
DownloadsMolfile
FormulaC22H32O4
Net Charge0
Average Mass360.494
Monoisotopic Mass360.23006
SMILES[H][C@]1(/C=C/[C@@H](O)C(C)CC#CC)[C@H](O)C[C@@H]2C/C(=C\CCCC(=O)O)C[C@@H]21
InChIInChI=1S/C22H32O4/c1-3-4-7-15(2)20(23)11-10-18-19-13-16(8-5-6-9-22(25)26)12-17(19)14-21(18)24/h8,10-11,15,17-21,23-24H,5-7,9,12-14H2,1-2H3,(H,25,26)/b11-10+,16-8+/t15?,17-,18+,19-,20+,21+/m0/s1
InChIKeyHIFJCPQKFCZDDL-ACWOEMLNSA-N
Wikipedia
Roles Classification
Chemical Role:
Bronsted acid  A molecular entity capable of donating a hydron to an acceptor (Brønsted base).
Applications:
anti-asthmatic agent  Any compound that has anti-asthmatic effects.
platelet aggregation inhibitor  A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
anticoagulant  An agent that prevents blood clotting.
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
cardiovascular drug  A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume.
vasodilator agent  A drug used to cause dilation of the blood vessels.
antihypertensive agent  Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
ChEBI Ontology
Outgoing Relation(s)
iloprost (CHEBI:63916) has role anti-asthmatic agent (CHEBI:65023)
iloprost (CHEBI:63916) has role anticoagulant (CHEBI:50249)
iloprost (CHEBI:63916) has role antihypertensive agent (CHEBI:35674)
iloprost (CHEBI:63916) has role antineoplastic agent (CHEBI:35610)
iloprost (CHEBI:63916) has role cardiovascular drug (CHEBI:35554)
iloprost (CHEBI:63916) has role platelet aggregation inhibitor (CHEBI:50427)
iloprost (CHEBI:63916) has role vasodilator agent (CHEBI:35620)
iloprost (CHEBI:63916) is a carbobicyclic compound (CHEBI:36785)
iloprost (CHEBI:63916) is a monocarboxylic acid (CHEBI:25384)
iloprost (CHEBI:63916) is a organic molecular entity (CHEBI:50860)
iloprost (CHEBI:63916) is a racemate (CHEBI:60911)
iloprost (CHEBI:63916) is a secondary alcohol (CHEBI:35681)
IUPAC Name 
(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]hexahydropentalen-2(1H)-ylidene]pentanoic acid
INNs  Source
iloprostChemIDplus
iloprostumChemIDplus
Synonyms  Source
(16R,S)-methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I2ChemIDplus
AurlumynChEMBL
ZK 00036374ChEMBL
ZK-00036374ChEMBL
Manual XrefsDatabases
1422DrugCentral
D02721KEGG DRUG
DB01088DrugBank
DE2845770Patent
IloprostWikipedia
US4692464Patent
Registry NumbersSources
Reaxys:4329060Reaxys
CAS:78919-13-8KEGG DRUG
Citations